Skip to the page

Data / Drug companies / Dextromethorphan polistirex

Dextromethorphan polistirex: 27 companies and 64 products in the FDA NDC directory

Dextromethorphan polistirex is listed in the FDA National Drug Code Directory by 27 companies, with 64 products in commercial distribution. 64 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are suspension; suspension, extended release, and the newest product started marketing on October 7, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
27
Products
64
Generic (ANDA) products
64 (100.0%)
Application numbers
3
Routes
Oral
Brand names
Cough DM, Cough DM, Robitussin 12 Hour Cough Relief, Basic Care Childrens Cough DM, Leader Cough DM, CareOne Cough DM, Foster and Thrive 12 Hour Cough Relief, Childrens Robitussin 12 Hour Cough Relief
openFDA record search
api.fda.gov

Companies that list dextromethorphan polistirex

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Amazon.com Services LLC6suspension; suspension, extended releaseGeneric drugs (ANDA)August 20, 2026
Haleon US Holdings LLC6suspension, extended releaseGeneric drugs (ANDA)July 5, 2016
Aurohealth LLC4suspension, extended releaseGeneric drugs (ANDA)April 17, 2026
Meijer Distribution Inc4suspension; suspension, extended releaseGeneric drugs (ANDA)March 26, 2015
Safeway4suspension; suspension, extended releaseGeneric drugs (ANDA)May 4, 2026
CVS Pharmacy3suspension; suspension, extended releaseGeneric drugs (ANDA)March 27, 2015
CVS Woonsocket Prescription Center, Incorporated3suspension; suspension, extended releaseGeneric drugs (ANDA)June 1, 2026
Cardinal Health 110, LLC. DBA Leader3suspension; suspension, extended releaseGeneric drugs (ANDA)June 6, 2017
Walgreen Company3suspension; suspension, extended releaseGeneric drugs (ANDA)July 1, 2015
American Sales Company2suspensionGeneric drugs (ANDA)August 23, 2013
Amneal Pharmaceuticals LLC2suspensionGeneric drugs (ANDA)August 1, 2017
Dolgencorp, Inc. (dollar General & Rexall)2suspensionGeneric drugs (ANDA)July 10, 2013
HyVee Inc2suspension, extended release; suspensionGeneric drugs (ANDA)May 18, 2015
Kroger Company2suspension; suspension, extended releaseGeneric drugs (ANDA)June 28, 2018
L. Perrigo Company2suspensionGeneric drugs (ANDA)June 20, 2013
Strategic Sourcing Services LLC2suspension, extended release; suspensionGeneric drugs (ANDA)October 4, 2023
Target Corporation2suspension; suspension, extended releaseGeneric drugs (ANDA)October 7, 2026
Topco Associates LLC2suspension; suspension, extended releaseGeneric drugs (ANDA)July 30, 2015
Wal-Mart Stores Inc2suspensionGeneric drugs (ANDA)July 21, 2015
Amerisource Bergen1suspensionGeneric drugs (ANDA)August 30, 2012
Atlantic Biologicals Corp.1suspensionGeneric drugs (ANDA)September 6, 2012
Bryant Ranch Prepack1suspensionGeneric drugs (ANDA)September 10, 2012
H E B1suspensionGeneric drugs (ANDA)August 30, 2012
Major Pharmaceuticals1suspensionGeneric drugs (ANDA)September 6, 2012
Padagis Israel Pharmaceuticals Ltd1suspensionGeneric drugs (ANDA)September 10, 2012
Publix Super Markets Inc1suspensionGeneric drugs (ANDA)February 25, 2014
United Natural Foods, Inc. DBA Unfi1suspensionGeneric drugs (ANDA)October 19, 2012

Dosage forms

Dosage formProductsShare
Suspension4164.1%
Suspension, extended release2335.9%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)64100%

Pharmacologic classes

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.